Predicted protein targets (top 2)
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3328080 | 0.76 | — | — | |
| SCHEMBL1644130 | 0.76 | — | — | |
| SCHEMBL13971139 | 0.76 | — | — | |
| SCHEMBL2645938 | 0.76 | — | — | |
| SCHEMBL3330387 | 0.76 | — | — | |
| SCHEMBL21349166 | 0.75 | GRIK1 (0.31) | — | |
| SCHEMBL14049813 | 0.74 | — | — | |
| SCHEMBL6039939 | 0.74 | — | — | |
| SCHEMBL12111046 | 0.74 | — | — | |
| Potassium Ion SCHEMBL14576205 | 0.72 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 18 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230340012-A1 | NATURAL AND SYNTHETIC COMPOUNDS FOR TREATING CANCER AND OTHER DISEASES | PACIFIC ARROW LTD (CN) | 2023-10-26 | — | — | US | disclosed |
| US-20230159436-A1 | APPLICATIONS OF AMIDE ANALOGS OF TRITERPENES IN CURES OF CANCER AND OTHER DISEASES | PACIFIC ARROW LTD (CN) | 2023-05-25 | — | — | US | disclosed |
| US-20200199172-A1 | NATURAL AND SYNTHETIC COMPOUNDS FOR TREATING CANCER AND OTHER DISEASES | PACIFIC ARROW LTD (CN) | 2020-06-25 | — | — | US | disclosed |
| US-10590163-B2 | Natural and synthetic compounds for treating cancer and other diseases | PACIFIC ARROW LIMITED (CN) | 2020-03-17 | — | — | US | disclosed |
| US-20170267714-A1 | NATURAL AND SYNTHETIC COMPOUNDS FOR TREATING CANCER AND OTHER DISEASES | PACIFIC ARROW LTD (CN) | 2017-09-21 | — | — | US | disclosed |
| US-20170022246-A1 | NATURAL AND SYNTHETIC COMPOUNDS FOR TREATING CANCER AND OTHER DISEASES | PACIFIC ARROW LTD (CN) | 2017-01-26 | — | — | US | disclosed |
| US-9499577-B2 | Natural and synthetic compounds for treating cancer and other diseases | PACIFIC ARROW LTD (CN) | 2016-11-22 | — | — | US | disclosed |
| US-9434677-B2 | Natural and synthetic compounds for treating cancer and other diseases | PACIFIC ARROW LIMITED (HK) | 2016-09-06 | — | — | US | disclosed |
| US-20140322810-A1 | NATURAL AND SYNTHETIC COMPOUNDS FOR TREATING CANCER AND OTHER DISEASES | PACIFIC ARROW LTD (CN) | 2014-10-30 | — | — | US | disclosed |
| US-20140199378-A1 | NEW NATURAL AND SYNTHETIC COMPOUNDS FOR TREATING CANCER AND OTHER DISEASES | PACIFIC ARROW LIMITED (CN) | 2014-07-17 | — | — | US | disclosed |
| CN-103857399-A | New natural and synthetic compounds for treating cancer and other diseases | PACIFIC ARROW LTD | 2014-06-11 | — | — | CN | disclosed |
| WO-2013012737-A1 | NEW NATURAL AND SYNTHETIC COMPOUNDS FOR TREATING CANCER AND OTHER DISEASES | PACIFIC ARROW LIMITED (VG) | 2013-01-24 | — | — | WO | disclosed |
| US-7560550-B2 | Method for the production of OH protected[4-(2.6-diamino-9H-purine-9-yl)-1.3-dioxolane-2-yl]methanol derivatives | RFS PHARMA, LLC (US) | 2009-07-14 | — | — | US | disclosed |
| EP-1648894-B1 | METHOD FOR THE PRODUCTION OF OH PROTECTED [4-(2.6-DIAMINO-9H-PURINE-9-YL)- 1.3-DIOXOLANE-2-YL]METHANOL DERIVATIVES | WACKER CHEMIE AG (DE) | 2007-09-12 | — | — | EP | disclosed |
| US-20060211855-A1 | Method for the production of oh protected{4-(2.6-diamino-9h-purine-9-yl)-1.3-dioxolane-2-yl] methanol derivatives | WACKER CHEMIE AG (DE) | 2006-09-21 | — | — | US | disclosed |
| EP-1648894-A1 | METHOD FOR THE PRODUCTION OF OH PROTECTED [4-(2.6-DIAMINO-9H-PURINE-9-YL)- 1.3-DIOXOLANE-2-YL]METHANOL DERIVATIVES | Wacker Chemie AG (DE) | 2006-04-26 | — | — | EP | disclosed |
| WO-2005012302-A1 | METHOD FOR THE PRODUCTION OF OH PROTECTED [4-(2.6-DIAMINO-9H-PURINE-9-YL)- 1.3-DIOXOLANE-2-YL]METHANOL DERIVATIVES | WACKER CHEMIE AG (DE) | 2005-02-10 | — | — | WO | disclosed |
| WO-2001044145-A1 | METHOD FOR THE MANUFACTURE OF OLEFINS | FORTUM OIL AND GAS OY (FI) | 2001-06-21 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (9 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20170022246-A1 | NATURAL AND SYNTHETIC COMPOUNDS FOR TREATING CANCER AND OTHER DISEASES | VCAM1, EPCAM, ICAM1 | ALDH1A1 2109/4885TDP1 4604/4885 |
| US-20200199172-A1 | NATURAL AND SYNTHETIC COMPOUNDS FOR TREATING CANCER AND OTHER DISEASES | VCAM1, EPCAM, ICAM1 | ALDH1A1 2097/4885TDP1 4610/4885 |
| US-20230340012-A1 | NATURAL AND SYNTHETIC COMPOUNDS FOR TREATING CANCER AND OTHER DISEASES | TEK, VCAM1, MCL1 | ALDH1A1 1090/4885TDP1 3722/4885 |
| US-10590163-B2 | Natural and synthetic compounds for treating cancer and other diseases | VCAM1, EPCAM, ICAM1 | ALDH1A1 2109/4885TDP1 4604/4885 |
| US-20230159436-A1 | APPLICATIONS OF AMIDE ANALOGS OF TRITERPENES IN CURES OF CANCER AND OTHER DISEASES | UACA, BRDT, FLT3 | ALDH1A1 1190/4885TDP1 4345/4885 |
| US-20140322810-A1 | NATURAL AND SYNTHETIC COMPOUNDS FOR TREATING CANCER AND OTHER DISEASES | VCAM1, EPCAM, ICAM1 | ALDH1A1 2109/4885TDP1 4604/4885 |
| US-20140199378-A1 | NEW NATURAL AND SYNTHETIC COMPOUNDS FOR TREATING CANCER AND OTHER DISEASES | VCAM1, EPCAM, TEK | ALDH1A1 2129/4885TDP1 4646/4885 |
| US-20060211855-A1 | Method for the production of oh protected{4-(2.6-diamino-9h-purine-9-yl)-1.3-dioxolane-2-yl] methanol derivatives | FUT6, FUT5, ST6GAL1 | ALDH1A1 187/4885TDP1 1083/4885 |
| US-20170267714-A1 | NATURAL AND SYNTHETIC COMPOUNDS FOR TREATING CANCER AND OTHER DISEASES | VCAM1, EPCAM, ICAM1 | ALDH1A1 2109/4885TDP1 4604/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.